Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS4902294 A
Publication typeGrant
Application numberUS 07/124,856
Publication dateFeb 20, 1990
Filing dateNov 30, 1987
Priority dateDec 3, 1986
Fee statusLapsed
Publication number07124856, 124856, US 4902294 A, US 4902294A, US-A-4902294, US4902294 A, US4902294A
InventorsOlivier Gosserez
Original AssigneeOlivier Gosserez
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Implantable mammary prosthesis adapted to combat the formation of a retractile shell
US 4902294 A
Abstract
An implantable mammary prosthesis designed to combat the formation around it of a retractile shell in reaction to a foreign body comprises a pocket with a front wall that can be inflated to a dome shape by injecting a physiological serum through a valve. The pocket is attached to a back wall to a sheet which is generally oval-shaped symmetrically relative to a major axis. The pocket is placed on the sheet so as to be spaced from the edges thereof on all sides by a distance of at least one fifth the radius of the pocket. The inside edge of the sheet, meaning that to be placed nearest the sternum, is narrower than the outside edge. The sheet is designed to impede retraction of the fibrous shell by creating a reflection line which breaks the continuity of curvature of the shell, so that the latter loses its retractile potential.
Images(1)
Previous page
Next page
Claims(16)
I claim:
1. Implantable mammary prosthesis adapted to combat the formation around it of a retractile shell in reaction to a foreign body, comprising a flexible pocket having a generally circular base, made from a surgical grade biocompatible film material and being dome shaped when filled with an appropriate fluid, and a substantially flat flexible sheet of surgical grade biocompatible film material, said circular base being integral with said flexible sheet, a base perimeter being defined on the flexible sheet at the perimeter of the circular base; wherein the improvement comprises a flexible peripheral flange formed by the flexible sheet extending continuously circumferentially around the base perimeter and extending outwardly therefrom a distance equal to at least one fifth the radius of said circular base, whereby said flexible periphery flange prevents fibrous membrane from causing capsular contraction about said mammary prosthesis.
2. Prosthesis according to claim 1, wherein the surface area of said sheet is at least twice that of said base of said pocket.
3. Prosthesis according to claim 1, wherein the periphery of said sheet has the shape of a closed curve free from sharp corners and free from points of inflection.
4. Prosthesis according to claim 3, wherein said sheet is of generally oval shape with major and minor axes and said base of said pocket has its center situated on said major axis, closer to one end thereof than the other.
5. Prosthesis according to claim 4, wherein said oval sheet has a maximal width along a line perpendicular to said major axis intersecting the same substantially at the center of said pocket base.
6. Prosthesis according to claim 1, wherein said biocompatible film material is medical grade silicone.
7. Prosthesis according to claim 1, further comprising means for inflating said flexible pocket in situ by injecting a physiologically acceptable liquid.
8. Prosthesis according to claim 7, wherein said pocket comprises a filling valve at the summit of its dome shape.
9. Prosthesis according to claim 1, wherein said flexible pocket is pre-filled with a silicone gel and hermetically sealed.
10. Implantable mammary prosthesis adapted to combat the formation around it of a retractile shell in reaction to a foreign body, said prosthesis having a generally circular base, said prosthesis being made from a biocompatible film material and being dome shaped when filled with an appropriate fluid, and a flexible sheet of biocompatible film material, said circular base being integral with said flexible sheet, a base perimeter being defined on the flexible sheet at the perimeter of the circular base; wherein the improvement comprises a flexible peripheral flange formed by the flexible sheet extending continuously circumferentially around the base perimeter and extending outwardly therefrom a distance equal to at least one fifth the radius of said circular base, the periphery of said flexible sheet having a shape of a closed curve free from sharp corners and free from points of inflection, said closed curve being of generally oval shape with major and minor axes, and said base of said pocket having its center situated on the major axis, the ratio of the distances from the center of said pocket base to respective ends of said major axis being at most 0.7:1.
11. Prosthesis according to claim 10, wherein the surface area of said sheet is at least twice that of said base of said pocket.
12. Prosthesis according to claim 10, wherein said oval sheet has a maximum width along a line perpendicular to said major axis, intersecting the same substantially at the center of said pocket base.
13. Prosthesis according to claim 10, wherein said biocompatible film material is medical grade silicone.
14. Prosthesis according to claim 10, further comprising means for inflating said flexible pocket in situ by injecting a physiologically acceptable liquid.
15. Prosthesis according to claim 14, wherein said pocket comprises a filling valve at the summit of its dome shape.
16. Prosthesis according to claim 10, wherein said pocket is prefilled with a silicone gel and hermetically sealed.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention

The invention relates to an implantable mammary prosthesis adapted to combat the formation around it of a retractile shell in reaction to a foreign body, comprising a flexible pocket having a generally circular base and made from a biocompatible film material filled out to a dome shape by filling it with an appropriate fluid.

2. Description of the prior art

Broadly speaking, conventional implantable mammary prostheses are divided into two categories: the so-called pre-filled prostheses which contain a silicone gel to maintain the dome shape of the pocket even before implantation, and the so-called inflatable prostheses which are formed to shape in situ by injecting a physiologically acceptable liquid of the physiological serum type.

Nevertheless, whichever category of prosthesis is used, its implantation leads to a foreign body reaction in the organism, this reaction manifesting itself in the formation of a living membrane made up of, among other things, fibroblast collagen and myofibroblasts which completely surround the prosthesis and isolate it from the organism.

In 70 to 80% of cases this membrane remains thin and flexible and does not lead to any modification of the shape or consistency of the fitted prosthesis.

In 20 to 30% of cases, however, over a period of months or years following implantation the membrane thickens and retracts to form a shell approximating the shape of a sphere to a greater or lesser degree. This geometrical shape is, of course, that for which the surface area to volume ratio is minimal. It goes without saying that the formation of a retractile shell of this kind is the opposite of the esthetic result looked for.

At the time of writing the problem raised by the risk of a retractile fibrous shell of this kind forming has not found a satisfactory solution. All attempted solutions relating to the membrane, to the content of the prosthesis, to the nature of the surface of the pocket and to the anatomical positioning of the prosthesis have proved unsatisfactory.

SUMMARY OF THE INVENTION

The invention consists in an implantable mammary prosthesis adapted to combat the formation around it of a retractile shell in reaction to a foreign body, comprising a flexible pocket having a generally circular base and made from a biocompatible film material filled out to a dome shape by filling it with an appropriate fluid and a flexible sheet of biocompatible film material from which said pocket projects and which has a peripheral edge surrounding said pocket, the distance between said edge and said pocket being substantially at least one fifth the radius of said pocket.

The inventor has noticed that in general surgery the introduction of a foreign material into the organism induces consistently a foreign body reaction but that the newly formed tissue does not show any comparable tendency to retraction. In surgical treatment of major hernias, in particular, large sheets or plates of woven material (dacron) or metal are implanted and induce non-retractile fibrous reactions.

The inventor was therefore led to reconsider the shape of mammary prostheses, which are approximately the same size in all three dimensions, and to design a prosthesis which comprises a sheet part, very thin in relation to its length and its width, which borders the pocket on all sides, so protecting it from retraction.

The surface area of the sheet is preferably at least twice that of the base of the pocket.

The periphery of the sheet preferably is in the shape of a closed curve without any sharp corners or points of inflection.

These conditions are directed to optimizing the defectiveness of the sheet.

Other characteristics and the advantages of the invention will emerge from the following description of one embodiment thereof, given with reference to the appended drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a perspective view of a prosthesis in accordance with the invention.

FIG. 2 is a plan view of the prosthesis shown in FIG. 1.

FIG. 3 is a cross-section on the line III--III in FIG. 2.

DESCRIPTION OF THE PREFERRED EMBODIMENT

In the chosen embodiment shown in the figures, the mammary prosthesis comprises a pocket 1 applied through its posterior surface 11 to a sheet 2, this posterior surface 11 adhering to the sheet over all of its area.

It should be made clear at once that the various parts of the prosthesis are qualified with reference to their position when fitted to the patient. Thus the posterior surface 11 of the pocket 1 will be that closest to the thorax.

The pocket 1 is of conventional construction in itself and thus may be of either of the two types of prosthesis that currently exist:

either an empty pocket, virtually empty before implantation, which is inflated with a physiological liquid through a valve 13 (this is the situation shown in the figures);

or a pre-filled and hermetically sealed pocket containing a silicone gel.

The prosthesis as a whole is made from a biocompatible material, for which there are numerous options available depending on the implantation site (on top of or behind the pectoral muscles).

The sheet 2 is made from a medical grade biocompatible film material and has a nearly oval shape symmetrical relative to its major axis which coincides with the section line III--III in FIG. 2. The pocket 1 is centered on the major axis of the sheet 2 and nearer the internal end of this major axis of the sheet 2 and nearer the internal end of this major axis that its external end. By internal end is meant that nearer the sternum after implantation.

The periphery of the pocket 1 is spaced from the edge of the sheet all the way round, so defining an inside edge 20, an outside edge 21, a lower edge 22 and an upper edge 23 of the sheet. The sheet has its maximal width between the lower edge 22 and the upper edge 23, substantially in line with the center of the pocket 1.

The fixing of the pocket 1 to the sheet is reinforced at the periphery of the posterior wall 11 by a bead 12. Continuity of the surface prevents any anchoring of the prosthesis.

As already explained in the preamble, the edges 20 through 23 are designed to keep away from the base of the pocket 1 the periphery of the fibrous membrane that will form around the prosthesis by virtue of foreign body reaction. It will be immediately understood that the effectiveness of the edges 20 through 23 is conditioned by their width, given the anatomical possibilities available for placing the prosthesis.

In the example shown, the inside edge 20, lower edge 22 and upper edge 23 have a minimal width close to one half the radius of the periphery of the pocket (excluding the bead 12, of course), whereas the outer edge 21 has a width of approximately 1.4 times the radius of the pocket 1.

The ratio of the distances along the major axis of the sheet 2 from the center of the pocket to the peripheries of the internal edge 20 and the external edge 21, respectively, is approximately 0.67:1.

This ratio allows for the anatomical constraints of the receiving site, limiting the possible extent of the sheet because of the necessity to preserve the adherence of the skin in the region of the sternum.

It will have been understood that the description has been given with reference to a right breast prosthesis but that, by virtue of the symmetry of the edges 22 and 23, it is sufficient to rotate the posthesis in the plane of FIG. 2 for it to be usable as a left breast, the lower edge becoming the upper edge and vice versa.

The example described here is considered to be the optimum for achieving a compromise between the effectiveness of protection against the formation of fibrous shells and anatomical compatibility with the typical patient. It will be understood, however, that it may be necessary to depart from the example as described for anatomical or other reasons. Experience indicates that the distance between the pocket 1 and the periphery of the sheet 2 should not be less than 1/5 of The radius of the pocket 1. Also, given that the total surface area of the sheet is an important parameter in combatting the appearance of fibrous shells, it is highly desirable for the surface area of the sheet to be at least twice that of the pocket 1.

Also, it has been stated that the periphery of the sheet should be a closed curve comprising neither sharp corners nor points of inflection. The presence of points of inflection produces re-entrant parts of the periphery and consequently a reduction in the useful surface area of the sheet relative to its total surface area.

It is to be understood that the invention is not limited to the examples described but rather encompasses any variant execution thereof within the scope of the appended claims.

Thus the pocket 1 could be molded in one piece with the sheet 2, rather than attached to it.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3452757 *Sep 14, 1966Jul 1, 1969Dow CorningTwo-way flushing device for treatment of hydrocephalus
US4125117 *Sep 26, 1977Nov 14, 1978Lee Denis CExternal breast prosthesis
US4195639 *Jul 13, 1978Apr 1, 1980Lee Denis CExternal breast prosthesis
US4264990 *Jun 28, 1979May 5, 1981Hamas Robert SMammary prosthesis
US4574780 *Nov 13, 1984Mar 11, 1986Manders Ernest KTissue expander and method
US4634443 *Jul 5, 1985Jan 6, 1987Habley Medical Technology CorporationSingle circuit elastofluidic sphincter
EP0005275A1 *May 5, 1979Nov 14, 1979Hans B. BauerfeindBreast prosthesis
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6001067 *Mar 4, 1997Dec 14, 1999Shults; Mark C.Device and method for determining analyte levels
US6146419 *Mar 3, 2000Nov 14, 2000Board Of Trustees Of The UniversityMethod for forming a hollow prosthesis
US6283998 *May 13, 1999Sep 4, 2001Board Of Trustees Of The University Of ArkansasAlloplastic vertebral disk replacement
US6315796May 13, 1999Nov 13, 2001Board Of Trustees Of The University Of ArkansasFlexible seamless memory tissue expanding implant
US6387133 *Jul 15, 1999May 14, 2002Laboratoire Perouse ImplantReconstruction implant
US6558321Aug 11, 2000May 6, 2003Dexcom, Inc.Systems and methods for remote monitoring and modulation of medical devices
US6702857Jul 27, 2001Mar 9, 2004Dexcom, Inc.Membrane for use with implantable devices
US6741877Jan 21, 2000May 25, 2004Dexcom, Inc.Device and method for determining analyte levels
US6862465Jul 27, 2001Mar 1, 2005Dexcom, Inc.Device and method for determining analyte levels
US7136689Jan 19, 2005Nov 14, 2006Dexcom, Inc.Device and method for determining analyte levels
US7471972Dec 22, 2004Dec 30, 2008Dexcom, Inc.Sensor head for use with implantable devices
US7613491Apr 14, 2006Nov 3, 2009Dexcom, Inc.Silicone based membranes for use in implantable glucose sensors
US7632228Jan 29, 2004Dec 15, 2009Dexcom, Inc.Membrane for use with implantable devices
US7711402Dec 22, 2004May 4, 2010Dexcom, Inc.Device and method for determining analyte levels
US7792562Dec 22, 2009Sep 7, 2010Dexcom, Inc.Device and method for determining analyte levels
US7835777Dec 22, 2009Nov 16, 2010Dexcom, Inc.Device and method for determining analyte levels
US7860545Feb 26, 2008Dec 28, 2010Dexcom, Inc.Analyte measuring device
US7885697Mar 10, 2005Feb 8, 2011Dexcom, Inc.Transcutaneous analyte sensor
US7970448Apr 19, 2010Jun 28, 2011Dexcom, Inc.Device and method for determining analyte levels
US7974672Apr 19, 2010Jul 5, 2011Dexcom, Inc.Device and method for determining analyte levels
US8064977Jul 29, 2009Nov 22, 2011Dexcom, Inc.Silicone based membranes for use in implantable glucose sensors
US8155723Jan 28, 2010Apr 10, 2012Dexcom, Inc.Device and method for determining analyte levels
US8160669Apr 11, 2007Apr 17, 2012Dexcom, Inc.Transcutaneous analyte sensor
US8216139Sep 23, 2009Jul 10, 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US8229535Feb 20, 2009Jul 24, 2012Dexcom, Inc.Systems and methods for blood glucose monitoring and alert delivery
US8233958Oct 12, 2009Jul 31, 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US8251906Apr 15, 2009Aug 28, 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US8257259Oct 16, 2008Sep 4, 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US8265725Oct 12, 2009Sep 11, 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US8265726Nov 9, 2009Sep 11, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8275437Mar 23, 2007Sep 25, 2012Dexcom, Inc.Transcutaneous analyte sensor
US8275439Nov 9, 2009Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8280475Feb 23, 2009Oct 2, 2012Dexcom, Inc.Transcutaneous analyte sensor
US8282549Dec 8, 2004Oct 9, 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US8282550Jul 29, 2008Oct 9, 2012Dexcom, Inc.Integrated receiver for continuous analyte sensor
US8287454Sep 27, 2010Oct 16, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8290561Sep 23, 2009Oct 16, 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US8311749May 26, 2011Nov 13, 2012Dexcom, Inc.Transcutaneous analyte sensor
US8313434Mar 1, 2007Nov 20, 2012Dexcom, Inc.Analyte sensor inserter system
US8313527Oct 30, 2008Nov 20, 2012Allergan, Inc.Soft prosthesis shell texturing method
US8321149Jun 29, 2011Nov 27, 2012Dexcom, Inc.Transcutaneous analyte sensor
US8346336Mar 18, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8346337Jun 30, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8364229May 18, 2007Jan 29, 2013Dexcom, Inc.Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US8366614Mar 30, 2009Feb 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8372423Apr 8, 2011Feb 12, 2013Healionics CorporationImplantable medical devices having microporous surface layers and method for reducing foreign body response to the same
US8374667Oct 16, 2008Feb 12, 2013Dexcom, Inc.Signal processing for continuous analyte sensor
US8380273Apr 11, 2009Feb 19, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8386004Sep 7, 2011Feb 26, 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US8391945Mar 17, 2009Mar 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8394021Oct 1, 2007Mar 12, 2013Dexcom, Inc.System and methods for processing analyte sensor data
US8409131Mar 7, 2007Apr 2, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8442610Aug 21, 2008May 14, 2013Dexcom, Inc.System and methods for processing analyte sensor data
US8452368Jan 14, 2009May 28, 2013Dexcom, Inc.Transcutaneous analyte sensor
US8465425Jun 30, 2009Jun 18, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8469886Sep 23, 2009Jun 25, 2013Dexcom, Inc.Signal processing for continuous analyte sensor
US8473021Jul 31, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8480580Apr 19, 2007Jul 9, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8487012Jan 25, 2011Jul 16, 2013Allergan, Inc.Open celled foams, implants including them and processes for making same
US8506627Aug 12, 2009Aug 13, 2013Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US8509871Oct 28, 2008Aug 13, 2013Dexcom, Inc.Sensor head for use with implantable devices
US8527025Nov 22, 1999Sep 3, 2013Dexcom, Inc.Device and method for determining analyte levels
US8527026Mar 2, 2012Sep 3, 2013Dexcom, Inc.Device and method for determining analyte levels
US8543184Oct 20, 2011Sep 24, 2013Dexcom, Inc.Silicone based membranes for use in implantable glucose sensors
US8546458Dec 7, 2011Oct 1, 2013Allergan, Inc.Process for texturing materials
US8565848May 7, 2009Oct 22, 2013Dexcom, Inc.Transcutaneous analyte sensor
US8591455Feb 20, 2009Nov 26, 2013Dexcom, Inc.Systems and methods for customizing delivery of sensor data
US8597189Mar 3, 2009Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8612159Feb 16, 2004Dec 17, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8617071Jun 21, 2007Dec 31, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8622906Dec 21, 2009Jan 7, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8641619Dec 21, 2009Feb 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8647393Dec 18, 2012Feb 11, 2014Healionics CorporationImplantable medical devices having microporous surface layers and method for reducing foreign body response to the same
US8649841Apr 3, 2007Feb 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8652043Jul 20, 2012Feb 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8657745Oct 16, 2008Feb 25, 2014Dexcom, Inc.Signal processing for continuous analyte sensor
US8660627Mar 17, 2009Feb 25, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8663109Mar 29, 2010Mar 4, 2014Dexcom, Inc.Transcutaneous analyte sensor
US8666469Nov 16, 2007Mar 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8668645Jan 3, 2003Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8670815Apr 30, 2007Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8676288Jun 22, 2011Mar 18, 2014Dexcom, Inc.Device and method for determining analyte levels
US8679279Nov 15, 2011Mar 25, 2014Allergan, Inc.Methods for creating foam-like texture
US8679570Apr 25, 2011Mar 25, 2014Allergan, Inc.Foam-like materials and methods for producing same
US8685296May 10, 2011Apr 1, 2014Allergan, Inc.Porogen compositions, method of making and uses
US8688188Jun 30, 2009Apr 1, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8734346Apr 30, 2007May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8734348Mar 17, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8738109Mar 3, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8744545Mar 3, 2009Jun 3, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8747315Sep 23, 2009Jun 10, 2014Dexcom. Inc.Signal processing for continuous analyte sensor
US8750955Nov 2, 2009Jun 10, 2014Dexcom, Inc.Analyte sensor
US8771187May 31, 2011Jul 8, 2014Dexcom, Inc.System and methods for processing analyte sensor data
US8774887Mar 24, 2007Jul 8, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8788007Mar 8, 2012Jul 22, 2014Dexcom, Inc.Transcutaneous analyte sensor
US8792953Mar 19, 2010Jul 29, 2014Dexcom, Inc.Transcutaneous analyte sensor
US8792955Jun 9, 2011Jul 29, 2014Dexcom, Inc.Transcutaneous analyte sensor
US8801610Jul 24, 2009Aug 12, 2014Dexcom, Inc.Signal processing for continuous analyte sensor
US8801782Dec 15, 2011Aug 12, 2014Allergan, Inc.Surgical methods for breast reconstruction or augmentation
US8840552Dec 8, 2009Sep 23, 2014Dexcom, Inc.Membrane for use with implantable devices
US8840553Feb 26, 2009Sep 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8845536Apr 11, 2007Sep 30, 2014Dexcom, Inc.Transcutaneous analyte sensor
US8877822Sep 27, 2011Nov 4, 2014Allergan, Inc.Porogen compositions, methods of making and uses
US8880137Apr 18, 2003Nov 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8889751Sep 28, 2011Nov 18, 2014Allergan, Inc.Porous materials, methods of making and uses
US8915849Feb 3, 2009Dec 23, 2014Dexcom, Inc.Transcutaneous analyte sensor
US8915850Mar 28, 2014Dec 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8920319Dec 28, 2012Dec 30, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8923947Jul 23, 2013Dec 30, 2014Dexcom, Inc.Device and method for determining analyte levels
US8927022Mar 3, 2010Jan 6, 2015Healionics CorporationGranules of porous biocompatible materials
US8951596Jul 15, 2013Feb 10, 2015Allergan, Inc.Implants and methods for manufacturing same
US8974386Nov 1, 2005Mar 10, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8986209Jul 13, 2012Mar 24, 2015Dexcom, Inc.Transcutaneous analyte sensor
US9011331Dec 29, 2004Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9011332Oct 30, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9014773Mar 7, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9020572Sep 10, 2010Apr 28, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US9042953Mar 2, 2007May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9044897Sep 28, 2011Jun 2, 2015Allergan, Inc.Porous materials, methods of making and uses
US9055901Sep 14, 2012Jun 16, 2015Dexcom, Inc.Transcutaneous analyte sensor
US9066694Apr 3, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066695Apr 12, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066697Oct 27, 2011Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9072477Jun 21, 2007Jul 7, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9072821Feb 4, 2011Jul 7, 2015Allergan, Inc.Biocompatible structures and compositions
US9078607Jun 17, 2013Jul 14, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9078626Mar 31, 2011Jul 14, 2015Dexcom, Inc.Transcutaneous analyte sensor
US9107623Apr 15, 2009Aug 18, 2015Dexcom, Inc.Signal processing for continuous analyte sensor
US9138308Aug 2, 2012Sep 22, 2015Apollo Endosurgery, Inc.Mucosal tissue adhesion via textured surface
US9138309Sep 24, 2012Sep 22, 2015Allergan, Inc.Porous materials, methods of making and uses
US9138310Oct 24, 2012Sep 22, 2015Allergan, Inc.Soft prosthesis shell texturing method
US9138311Jul 29, 2013Sep 22, 2015Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US9143569Feb 20, 2009Sep 22, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US9155613Feb 6, 2014Oct 13, 2015Allergan, Inc.Methods for creating foam-like texture
US9192328Sep 23, 2009Nov 24, 2015Dexcom, Inc.Signal processing for continuous analyte sensor
US9205577Sep 28, 2012Dec 8, 2015Allergan, Inc.Porogen compositions, methods of making and uses
US9326714Jun 29, 2010May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9326716Dec 5, 2014May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9328371Jul 16, 2013May 3, 2016Dexcom, Inc.Sensor head for use with implantable devices
US9339223Dec 30, 2013May 17, 2016Dexcom, Inc.Device and method for determining analyte levels
US9351668Oct 12, 2009May 31, 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US9364173Sep 23, 2009Jun 14, 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US9393106May 8, 2014Jul 19, 2016Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US9399122Dec 9, 2015Jul 26, 2016Reconstructive Technologies, LlcSystems and methods for a tissue expander
US9414777Mar 10, 2005Aug 16, 2016Dexcom, Inc.Transcutaneous analyte sensor
US9420965Jul 1, 2011Aug 23, 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US9427183Jul 12, 2011Aug 30, 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9439589Nov 25, 2014Sep 13, 2016Dexcom, Inc.Device and method for determining analyte levels
US9498155Oct 16, 2008Nov 22, 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US9498159Oct 30, 2007Nov 22, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9522502Oct 13, 2014Dec 20, 2016Allergan, Inc.Porous materials, methods of making and uses
US9532741Jul 25, 2014Jan 3, 2017Dexcom, Inc.Membrane for use with implantable devices
US9538946Mar 25, 2010Jan 10, 2017Dexcom, Inc.Integrated receiver for continuous analyte sensor
US9539086May 15, 2015Jan 10, 2017Allergan, Inc.Soft filled prosthesis shell with variable texture
US9549693Jul 25, 2013Jan 24, 2017Dexcom, Inc.Silicone based membranes for use in implantable glucose sensors
US9593224Oct 1, 2014Mar 14, 2017Allergan, Inc.Porogen compositions, methods of making and uses
US20030032874 *Jul 27, 2001Feb 13, 2003Dexcom, Inc.Sensor head for use with implantable devices
US20030093151 *Dec 19, 2002May 15, 2003Guangzhou Wanhe Material Co. Ltd.Implantable mammary prosthesis with flexible sheet
US20040126404 *Jul 29, 2003Jul 1, 2004University Of Queensland Of St. LuciaImplant material
US20040167801 *Feb 16, 2004Aug 26, 2004James SayAnalyte monitoring device and methods of use
US20040186362 *Jan 29, 2004Sep 23, 2004Dexcom, Inc.Membrane for use with implantable devices
US20050033132 *May 14, 2004Feb 10, 2005Shults Mark C.Analyte measuring device
US20050103625 *Dec 22, 2004May 19, 2005Rathbun RhodesSensor head for use with implantable devices
US20050177036 *Dec 22, 2004Aug 11, 2005Shults Mark C.Device and method for determining analyte levels
US20050203360 *Dec 8, 2004Sep 15, 2005Brauker James H.Signal processing for continuous analyte sensor
US20060189863 *Nov 1, 2005Aug 24, 2006Abbott Diabetes Care, Inc.Analyte monitoring device and methods of use
US20070032718 *Oct 10, 2006Feb 8, 2007Shults Mark CDevice and method for determining analyte levels
US20070163880 *Mar 1, 2007Jul 19, 2007Dexcom, Inc.Analyte sensor
US20070179370 *Apr 3, 2007Aug 2, 2007Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20070191699 *Apr 3, 2007Aug 16, 2007Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20070203410 *Apr 30, 2007Aug 30, 2007Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20070203872 *Mar 24, 2007Aug 30, 2007Manyworlds, Inc.Affinity Propagation in Adaptive Network-Based Systems
US20070203966 *Mar 23, 2007Aug 30, 2007Dexcom, Inc.Transcutaneous analyte sensor
US20070208244 *Apr 11, 2007Sep 6, 2007Brauker James HTranscutaneous analyte sensor
US20070208246 *Apr 11, 2007Sep 6, 2007Brauker James HTranscutaneous analyte sensor
US20070235331 *May 18, 2007Oct 11, 2007Dexcom, Inc.Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20070244379 *Apr 14, 2006Oct 18, 2007Robert BoockSilicone based membranes for use in implantable glucose sensors
US20070244380 *Jun 21, 2007Oct 18, 2007Abbott Diabetes Care, Inc.Analyte monitoring device and methods of use
US20070249919 *Jun 21, 2007Oct 25, 2007Abbott Diabetes Care, Inc.Analyte monitoring device and methods of use
US20070249920 *Jun 21, 2007Oct 25, 2007Abbott Diabetes Care, Inc.Analyte monitoring device and methods of use
US20080021666 *Oct 1, 2007Jan 24, 2008Dexcom, Inc.System and methods for processing analyte sensor data
US20080033271 *Jun 21, 2007Feb 7, 2008Abbott Diabetes Care, Inc.Analyte monitoring device and methods of use
US20080076997 *Aug 31, 2007Mar 27, 2008Abbott Diabetes Care, Inc.Analyte monitoring device and methods of use
US20080091096 *Nov 16, 2007Apr 17, 2008Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20080268017 *May 15, 2008Oct 30, 2008The University Of Queensland Of St. LuciaMethod of producing tissue by placing a molding support within a body cavity
US20080287764 *Jul 29, 2008Nov 20, 2008Dexcom, Inc.Integrated receiver for continuous analyte sensor
US20080287765 *Jul 29, 2008Nov 20, 2008Dexcom, Inc.Integrated receiver for continuous analyte sensor
US20080306368 *Aug 21, 2008Dec 11, 2008Dexcom, Inc.System and methods for processing analyte sensor data
US20090030294 *Oct 7, 2008Jan 29, 2009Dexcom, Inc.Implantable analyte sensor
US20090043182 *Oct 16, 2008Feb 12, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20090043525 *Oct 16, 2008Feb 12, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20090043541 *Oct 16, 2008Feb 12, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20090043542 *Oct 16, 2008Feb 12, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20090062635 *Nov 3, 2008Mar 5, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20090118829 *Oct 30, 2008May 7, 2009Allergan, Inc.Soft prosthesis shell texturing method
US20090124879 *Jan 14, 2009May 14, 2009Dexcom, Inc.Transcutaneous analyte sensor
US20090149953 *Nov 20, 2008Jun 11, 2009Schuessler David JForm stable breast implant sizer and method of use
US20090163789 *Mar 3, 2009Jun 25, 2009Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20090163791 *Feb 23, 2009Jun 25, 2009Dexcom, Inc.Transcutaneous analyte sensor
US20090171179 *Mar 3, 2009Jul 2, 2009Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20090177054 *Mar 3, 2009Jul 9, 2009Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20090177064 *Mar 17, 2009Jul 9, 2009Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20090182212 *Mar 17, 2009Jul 16, 2009Abbott Diabetes Care, Inc.Analyte Monitoring Device and Methods of Use
US20090192370 *Mar 30, 2009Jul 30, 2009Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of Use
US20090192724 *Feb 3, 2009Jul 30, 2009Dexcom, Inc.Transcutaneous analyte sensor
US20090198175 *Apr 11, 2009Aug 6, 2009Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of Use
US20090203981 *Apr 15, 2009Aug 13, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20090204341 *Apr 15, 2009Aug 13, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20090216102 *Feb 26, 2009Aug 27, 2009James SayAnalyte Monitoring Device and Methods of Use
US20090216103 *May 7, 2009Aug 27, 2009Dexcom, Inc.Transcutaneous analyte sensor
US20090240120 *Feb 20, 2009Sep 24, 2009Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US20090240128 *Feb 20, 2009Sep 24, 2009Dexcom, Inc.Systems and methods for blood glucose monitoring and alert delivery
US20090240193 *Feb 20, 2009Sep 24, 2009Dexcom, Inc.Systems and methods for customizing delivery of sensor data
US20090252689 *Mar 31, 2009Oct 8, 2009Jennifer Reichl CollinHair styling composition
US20090287073 *Jul 29, 2009Nov 19, 2009Dexcom, Inc.Silicone based membranes for use in implantable glucose sensors
US20090299162 *Jul 24, 2009Dec 3, 2009Dexcom, Inc.Signal processing for continuous analyte sensor
US20100010324 *Sep 23, 2009Jan 14, 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100010331 *Sep 23, 2009Jan 14, 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100010332 *Sep 23, 2009Jan 14, 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100016687 *Sep 23, 2009Jan 21, 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100016698 *Sep 23, 2009Jan 21, 2010Dexcom, Inc.Integrated receiver for continuous analyte sensor
US20100022855 *Sep 23, 2009Jan 28, 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100030038 *Oct 12, 2009Feb 4, 2010Dexcom. Inc.Signal processing for continuous analyte sensor
US20100030484 *Sep 23, 2009Feb 4, 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100030485 *Oct 12, 2009Feb 4, 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100042211 *May 1, 2009Feb 18, 2010Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US20100042212 *Aug 12, 2009Feb 18, 2010Allergan, Inc.Soft Filled Prosthesis Shell With Discrete Fixation Surfaces
US20100045465 *Oct 12, 2009Feb 25, 2010Dexcom Inc.Signal processing for continuous analyte sensor
US20100056889 *Nov 9, 2009Mar 4, 2010James SayAnalyte Monitoring Device And Methods Of Use
US20100087724 *Dec 8, 2009Apr 8, 2010Dexcom, Inc.Membrane for use with implantable devices
US20100094110 *Jun 30, 2009Apr 15, 2010Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of Use
US20100094112 *Jun 30, 2009Apr 15, 2010Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of Use
US20100179401 *Mar 25, 2010Jul 15, 2010Dexcom, Inc.Integrated receiver for continuous analyte sensor
US20100185069 *Mar 30, 2010Jul 22, 2010Dexcom, Inc.Transcutaneous analyte sensor
US20100185075 *Mar 29, 2010Jul 22, 2010Dexcom, Inc.Transcutaneous analyte sensor
US20100204555 *Apr 19, 2010Aug 12, 2010Dexcom, Inc.Device and method for determining analyte levels
US20100204559 *Apr 19, 2010Aug 12, 2010Dexcom, Inc.Device and method for determining analyte levels
US20100268048 *Jun 29, 2010Oct 21, 2010Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of Use
US20100268049 *Jun 29, 2010Oct 21, 2010Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of Use
US20100274111 *Jun 29, 2010Oct 28, 2010Abbott Diabetes Care Inc.Analyte Monitoring Device and Methods of Use
US20100292790 *May 12, 2010Nov 18, 2010Allergan, Inc.Implants and methods for manufacturing same
US20110093069 *Oct 4, 2010Apr 21, 2011Allergan, Inc.Implants and methdos for manufacturing same
US20110117267 *Jan 21, 2011May 19, 2011Allergan, Inc.Soft Prosthesis Shell Texturing Method
US20110184531 *Jan 25, 2011Jul 28, 2011Allergan, Inc.Open celled foams, implants including them and processes for making same
US20110196488 *Jan 27, 2011Aug 11, 2011Allergan, Inc.Degradation resistant implantable materials and methods
US20110231107 *May 26, 2011Sep 22, 2011Dexcom, Inc.Transcutaneous analyte sensor
US20110231140 *May 31, 2011Sep 22, 2011Dexcom, Inc.System and methods for processing analyte sensor data
US20110231142 *May 31, 2011Sep 22, 2011Dexcom, Inc.System and methods for processing analyte sensor data
WO2002051337A1 *Dec 21, 2001Jul 4, 2002Guangzhou Wanhe Material Co., Ltd.Artificial mammary prosthesis having a skirt
WO2004041128A1 *Oct 23, 2002May 21, 2004Laboratoires EurosiliconeAnatomical breast implant with controllable and stable positioning
Classifications
U.S. Classification623/8
International ClassificationA61F2/12
Cooperative ClassificationA61F2/12
European ClassificationA61F2/12
Legal Events
DateCodeEventDescription
Nov 10, 1993REMIMaintenance fee reminder mailed
Jan 12, 1994SULPSurcharge for late payment
Jan 12, 1994FPAYFee payment
Year of fee payment: 4
Sep 30, 1997REMIMaintenance fee reminder mailed
Feb 22, 1998LAPSLapse for failure to pay maintenance fees
May 5, 1998FPExpired due to failure to pay maintenance fee
Effective date: 19980225